# A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution

> **NCT04132570** · PHASE4 · COMPLETED · sponsor: **Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division** · enrollment: 206 (actual)

## Conditions studied

- Rhinitis

## Interventions

- **DRUG:** Budesonide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04132570
- **Lead sponsor:** Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-22
- **Primary completion:** 2020-01-22
- **Final completion:** 2020-01-22
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04132570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04132570, "A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04132570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*